The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.

The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.
复制标题

DOI:
10.4049/jimmunol.1300611
复制
发表时间:
2013-12-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Siebenlist U
Siebenlist U
中科院分区:
其他
文献类型:
--
作者:
Zhang X;Paun A;Claudio E;Wang H;Siebenlist U

文献摘要

参考文献

被引文献

相似文献

Bcl-3是IκB蛋白家族的非典型成员。与经典成员不同,Bcl-3作为核转录辅因子发挥功能,根据上下文,可以通过与p50/NF-κB1或p52/NF-κB2同源二聚体的结合来促进或抑制基因。Bcl-3也是一种致癌基因,因为它是B细胞肿瘤中复发性易位的伴侣,导致表达失调。然而,Bcl-3的功能仍然知之甚少。我们已经研究了Bcl-3在B细胞中的作用,并发现了以前未知的参与这些细胞的脾发育。B细胞中Bcl-3的缺失导致显著更多的边缘区(MZ)和更少的滤泡(FO)B细胞。相反,在B细胞中转基因表达Bcl-3产生更少的MZ和更多的FO B细胞。与野生型细胞相比,Bcl-3−/− FO和MZ B细胞对LPS刺激的反应更强,包括增殖增加。相比之下,Bcl-3−/− FO B细胞在B细胞受体(BCR)刺激下更容易发生凋亡,也限制了它们的扩增。数据揭示Bcl-3作为B细胞命运决定的调节剂,限制MZ途径并有利于FO途径,至少部分地通过增加后者的信号特异性存活,这是与其致瘤活性相关的发现。
Bcl-3 is an atypical member of the family of IκB proteins. Unlike the classic members, Bcl-3 functions as a nuclear transcriptional cofactor that may, depending on context, promote or suppress genes via association with p50/NF-κB1 or p52/NF-κB2 homodimers. Bcl-3 is also an oncogene, since it is a partner in recurrent translocations in B cell tumors, resulting in deregulated expression. Bcl-3’s functions, however, remain poorly understood. We have investigated Bcl-3’s role in B cells and discovered a previously unknown involvement in the splenic development of these cells. Loss of Bcl-3 in B cells resulted in significantly more marginal zone (MZ) and fewer follicular (FO) B cells. Conversely, transgenic expression of Bcl-3 in B cells generated fewer MZ and more FO B cells. Both Bcl-3−/− FO and MZ B cells were more responsive to LPS stimulation compared with their wild-type counterparts, including increased proliferation. By contrast, Bcl-3−/− FO B cells were more prone to apoptosis upon B cell receptor (BCR) stimulation, also limiting their expansion. The data reveal Bcl-3 as a regulator of B cell fate determination, restricting the MZ path and favoring the FO pathway, at least in part via increased signal-specific survival of the latter, a finding of relevance to its tumorigenic activity.
DOI: 10.1186/1476-4598-10-152
发表时间: 2011-12-23
期刊: Molecular cancer
影响因子: 37.3
作者:
Maldonado V;Melendez-Zajgla J
通讯作者: Melendez-Zajgla J
DOI: 10.1111/j.1600-0609.2011.01684.x
发表时间: 2011-12-01
影响因子: 3.1
作者:
Ibrahim, Hazem A. H.;Amen, Furrat;Naresh, Kikkeri N.
通讯作者: Naresh, Kikkeri N.
DOI: 10.1084/jem.20070318
发表时间: 2007-10-29
期刊: The Journal of experimental medicine
影响因子: --
作者:
Hövelmeyer N;Wunderlich FT;Massoumi R;Jakobsen CG;Song J;Wörns MA;Merkwirth C;Kovalenko A;Aumailley M;Strand D;Brüning JC;Galle PR;Wallach D;Fässler R;Waisman A
通讯作者: Waisman A
DOI: 10.1182/blood-2008-02-140814
发表时间: 2008-11-15
期刊: Blood
影响因子: 20.3
作者:
Meyer-Bahlburg A;Becker-Herman S;Humblet-Baron S;Khim S;Weber M;Bouma G;Thrasher AJ;Batista FD;Rawlings DJ
通讯作者: Rawlings DJ
DOI: 10.1128/mcb.01600-09
发表时间: 2010-08-01
影响因子: 5.3
作者:
Keutgens, Aurore;Shostak, Kateryna;Chariot, Alain
通讯作者: Chariot, Alain